Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 59-65

  Hara, Hiroshi ^a   Yamada, Norihito ^a   Kodama, Masazumi ^a   Matsumoto, Yosuke ^a   Wake, Yosuke ^a   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

(Rat); AMPA receptor antagonists; Epileptogenesis; Kindling; YM872

Indexed keywords

[1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; DRUG SOLUBILITY; EPILEPSY; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; EPILEPSY; IMIDAZOLES; KINDLING, NEUROLOGIC; MALE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; TIME FACTORS;

EID: 32044440052     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.044     Document Type: Article

References (26)

1. Y.P. Auberson Competitive AMPA antagonism: a novel mechanism for antiepileptic drugs? Drugs Future 26 2001 463 471
2. B.J. Chiasson, Z. Dennison, and H.A. Robertson Amygdala kindling and immediate-early genes Mol. Brain Res. 29 1995 191 199
3. M. Clark, R.M. Post, S.R.B. Weiss, C.J. Cain, and T. Nakajima Regional expression of c-fos mRNA in rat brain during the evolution of amygdala kindled seizures Mol. Brain Res. 11 1991 55 64
4. Z. Dennison, G.C. Teskey, and D.P. Cain Persistence of kindling: effect of partial kindling, retention interval, kindling site, and stimulation parameters Epilepsy Res. 21 1995 171 182
5. M. Dragunow, and H.A. Robertson Kindling stimulation induced c-fos protein(s) in granule cells of the rat dentate gyrus Nature 329 1987 441 442
6. M. Dragunow, H.A. Robertson, and G.S. Robertson Amygdala kindling and c-fos protein(s) Exp. Neurol. 102 1988 261 263
7. N. Dürmüller, M. Craggs, and B.S. Meldrum The effect of the non-NMDA r466 and NBQX and the competitive NMDA receptor antagonists D-CPPene on the development of amygdala-kindling and on amygdala-kindled seizures Epilepsy Res. 17 1994 167 174
8. A. Häberg, M. Takahashi, T. Yamaguchi, M. Hjeistuen, and O. Haraldseth Neuroprotective effect of novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion Brain Res. 811 1998 63 70
9. S. Kawasaki-Yatsugi, S. Yatsugi, M. Takahashi, T. Toya, C. Ichiki, M. Shimizu-Sasamata, T. Yamaguchi, and K. Minematsu A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats Brain Res. 793 1998 39 46
10. S. Kawasaki-Yatsugi, C. Ichiki, S. Yatsugi, M. Takahashi, M. Shimizu-Sasamata, T. Yamaguchi, and K. Mimatsu Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model Neuropharmacology 39 2000 211 217
11. M. Kodama, N. Yamada, K. Sato, Y. Kitamura, F. Koyama, T. Sato, K. Morimoto, and S. Kuroda Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat Eur. J. Pharmacol. 374 1999 11 19
12. A. Kohara, M. Okada, R. Tsutsumi, K. Ohno, M. Takahashi, M. Shimizu-Sasamata, J. Shishikura, H. Inami, S. Sakamoto, and T. Yamaguchi In-vitro characterization of YM872, a selective, potent and highly water-soluble α-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptor antagonist J. Pharm. Pharmacol. 50 1998 795 801
13. W. Löscher Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy Prog. Neurobiol. 54 1998 721 741
14. B.S. Meldrum The role of glutamate in epilepsy and other CNS disorders Neurology 44 Suppl. 8 1994 S14 S23
15. D.T. Monaghan, D. Yao, and C.W. Cotman Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography Brain Res. 324 1984 160 164
16. K. Morimoto, K. Katayama, K. Inoue, and K. Sato Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP Pharmacol. Biochem. Behav. 40 1991 893 899
17. T. Namba, K. Morimoto, N. Yamada, and S. Otsuki Antiepileptogenic action of 7-chlorokynurenic acid on amygdala-kindling of rats Pharmacol. Biochem. Behav. 46 1993 275 281
18. T. Namba, K. Morimoto, K. Sato, N. Yamada, and S. Kuroda Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy Brain Res. 638 1994 36 44
19. L. Pickard, J. Noël, J.M. Henlez, G.L. Collingridge, and E. Molnar Developmental change in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons J. Neurosci. 20 2000 7922 7931
20. R.J. Racine Modification of seizures activity by electrical stimulation: 2 Motor seizure Electroencephalogr. Clin. Neurophysiol. 32 1972 281 294
21. K. Sato, K. Morimoto, and M. Okamoto Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy Brain Res. 463 1988 12 20
22. T. Sato, N. Yamada, K. Morimoto, S. Uemura, and S. Kuroda A behavioral and immunohistchemical study on the development of perirhinal cortical kindling: a comparison with other types of limbic kindling Brain Res. 811 1998 122 132
23. M. Shimizu-Sasamata, T. Kano, J. Rogowska, G.L. Wolf, M.A. Moskowitz, and E.H. Lo YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats Stroke 29 1998 2141 2148
24. J.M. Silver, C. Shin, and J.O. McNamara Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy Ann. Neurol. 29 1991 356 363
25. M. Takahashi, J.W. Ni, S. Kawasaki-Yatsugi, T. Toya, C. Ichiki, S. Yatsugi, K. Koshiya, M. Shimizu-Sasamata, and T. Yamaguchi Neuroprotective efficacy of YM872, an α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptor antagonist, after permanent middle cerebral artery occlusion in rats J. Pharmacol. Exp. Ther. 287 1998 559 566
26. H. Yamashita, K. Ohno, H. Inami, J. Shishikura, S. Sakamoto, M. Okada, and T. Yamaguchi Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy Eur. J. Pharmacol. 494 2004 147 154